| Dr Sara Anne Papa, OTD, OTR/L | |
|
8830 Virginia St, Amelia Court House, VA 23002-4826 | |
| (804) 561-7959 | |
| Not Available |
| Full Name | Dr Sara Anne Papa |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 8830 Virginia St, Amelia Court House, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205489697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119008266 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sara Anne Papa, OTD, OTR/L 13506 Buck Rub Dr, Midlothian, VA 23112-1939 Ph: (703) 347-2415 | Dr Sara Anne Papa, OTD, OTR/L 8830 Virginia St, Amelia Court House, VA 23002-4826 Ph: (804) 561-7959 |
News Archive
Scientists from the University of Cambridge have grown miniature functional models of the womb lining in culture, representing a major step forwards in the study of early-stage pregnancy and conditions such as endometriosis.
A major new study led by Flinders University Professor Derek Chew shows that up to 70% of patients presenting to Australian hospital emergency departments with chest pain could be safely discharged in less time than they currently are under standard Australian protocols.
Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic's Endeavor(R) Stent highlighting significant and sustained clinical differences. These important findings were presented at the American College of Cardiology annual meeting, (ACC 2010) in Atlanta and published on-line in the prestigious journal The Lancet.
USAID's "IMPACTblog" interviews Regina Ombam, head of strategy for the Kenya National AIDS Control Council (NACC), and Irene Mukui, the antiretroviral therapy (ART) program manager for Kenya's National AIDS and STI Control Program, regarding a Cabinet memorandum prepared by the NACC in March that outlines ways to raise funds for HIV programming.
AspenBio Pharma, Inc., an emerging bio-science company dedicated to the development of novel diagnostics and drugs for humans and animals, reported on its progress and plans for the Premarket Notification 510(k) submission of its ELISA format AppyScore™ test. AppyScore is the first blood-based test designed to aid in the evaluation of patients suspected of having acute appendicitis.
› Verified 1 days ago